The epidemiological modelling of dysthymia: application for the Global Burden of Disease Study 2010
- PMID: 23806588
- DOI: 10.1016/j.jad.2013.05.060
The epidemiological modelling of dysthymia: application for the Global Burden of Disease Study 2010
Abstract
Background: In order to capture the differences in burden between the subtypes of depression, the Global Burden of Disease 2010 Study for the first time estimated the burden of dysthymia and major depressive disorder separately from the previously used umbrella term 'unipolar depression'. A global summary of epidemiological parameters are necessary inputs in burden of disease calculations for 21 world regions, males and females and for the year 1990, 2005 and 2010. This paper reports findings from a systematic review of global epidemiological data and the subsequent development of an internally consistent epidemiological model of dysthymia.
Methods: A systematic search was conducted to identify data sources for the prevalence, incidence, remission and excess-mortality of dysthymia using Medline, PsycINFO and EMBASE electronic databases and grey literature. DisMod-MR, a Bayesian meta-regression tool, was used to check the epidemiological parameters for internal consistency and to predict estimates for world regions with no or few data.
Results: The systematic review identified 38 studies meeting inclusion criteria which provided 147 data points for 30 countries in 13 of 21 world regions. Prevalence increases in the early ages, peaking at around 50 years. Females have higher prevalence of dysthymia than males. Global pooled prevalence remained constant across time points at 1.55% (95%CI 1.50-1.60). There was very little regional variation in prevalence estimates.
Limitations: There were eight GBD world regions for which we found no data for which DisMod-MR had to impute estimates.
Conclusion: The addition of internally consistent epidemiological estimates by world region, age, sex and year for dysthymia contributed to a more comprehensive estimate of mental health burden in GBD 2010.
Keywords: Dysthymia; Epidemiology; Global public health; Mental disorders; Statistical modelling; Systematic review.
© 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010.J Child Psychol Psychiatry. 2013 Dec;54(12):1263-74. doi: 10.1111/jcpp.12144. Epub 2013 Oct 4. J Child Psychol Psychiatry. 2013. PMID: 24117530
-
Surgical interventions for treating intracapsular hip fractures in older adults: a network meta-analysis.Cochrane Database Syst Rev. 2022 Feb 14;2(2):CD013404. doi: 10.1002/14651858.CD013404.pub2. Cochrane Database Syst Rev. 2022. PMID: 35156192 Free PMC article.
-
Antidepressants for the treatment of depression in people with cancer.Cochrane Database Syst Rev. 2018 Apr 23;4(4):CD011006. doi: 10.1002/14651858.CD011006.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2023 Mar 31;3:CD011006. doi: 10.1002/14651858.CD011006.pub4. PMID: 29683474 Free PMC article. Updated.
-
Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021.Lancet Gastroenterol Hepatol. 2024 Sep;9(9):825-858. doi: 10.1016/S2468-1253(24)00157-2. Epub 2024 Jul 17. Lancet Gastroenterol Hepatol. 2024. PMID: 39032499 Free PMC article.
-
Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.Cochrane Database Syst Rev. 2022 Feb 10;2(2):CD013405. doi: 10.1002/14651858.CD013405.pub2. Cochrane Database Syst Rev. 2022. PMID: 35142366 Free PMC article.
Cited by
-
The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010.PLoS One. 2013 Jul 29;8(7):e69637. doi: 10.1371/journal.pone.0069637. Print 2013. PLoS One. 2013. PMID: 23922765 Free PMC article.
-
A review of the 257 meta-analyses of the differences between females and males in prevalence and risk, protective factors, and treatment outcomes for mental disorder.BMC Psychiatry. 2025 Jul 3;25(1):677. doi: 10.1186/s12888-025-06848-7. BMC Psychiatry. 2025. PMID: 40610965 Free PMC article.
-
Modified Xiaochaihu Decoction Combined with Mirtazapine in the Treatment of Persistent Depression: A Pilot Randomized Controlled Trial.Contrast Media Mol Imaging. 2022 Jun 27;2022:8682612. doi: 10.1155/2022/8682612. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35833082 Free PMC article. Clinical Trial.
-
Evaluation of Serum Glial Cell Line-derived Neurotrophic Factor in Bangladeshi Major Depressive Disorder Patients.Cureus. 2019 Nov 6;11(11):e6081. doi: 10.7759/cureus.6081. Cureus. 2019. PMID: 31853432 Free PMC article.
-
Comparing a ses-sensitive and an all-ses implementation strategy to improve participation rates of patients with a lower socioeconomic background in a web-based intervention for depressive complaints: a cluster randomised trial in primary care.BMC Prim Care. 2022 Aug 11;23(1):205. doi: 10.1186/s12875-022-01793-w. BMC Prim Care. 2022. PMID: 35948866 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources